Prescott Group Capital Management L.L.C. Invests $818,000 in Teladoc Health, Inc. (NYSE:TDOC)

Prescott Group Capital Management L.L.C. purchased a new position in shares of Teladoc Health, Inc. (NYSE:TDOC - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 90,000 shares of the health services provider's stock, valued at approximately $818,000. Prescott Group Capital Management L.L.C. owned approximately 0.05% of Teladoc Health at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. Private Advisor Group LLC increased its stake in shares of Teladoc Health by 26.9% during the third quarter. Private Advisor Group LLC now owns 13,990 shares of the health services provider's stock worth $128,000 after purchasing an additional 2,962 shares during the period. International Assets Investment Management LLC lifted its stake in Teladoc Health by 693.0% during the third quarter. International Assets Investment Management LLC now owns 23,299 shares of the health services provider's stock worth $214,000 after purchasing an additional 20,361 shares during the last quarter. Wealth Enhancement Advisory Services LLC acquired a new stake in shares of Teladoc Health in the 3rd quarter valued at $111,000. Janney Montgomery Scott LLC increased its stake in shares of Teladoc Health by 63.0% in the 3rd quarter. Janney Montgomery Scott LLC now owns 106,727 shares of the health services provider's stock valued at $980,000 after purchasing an additional 41,250 shares during the last quarter. Finally, Robeco Institutional Asset Management B.V. lifted its position in shares of Teladoc Health by 141.9% during the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 575,055 shares of the health services provider's stock worth $5,279,000 after buying an additional 337,305 shares during the last quarter. Institutional investors and hedge funds own 76.82% of the company's stock.

Remove Ads

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on TDOC. Oppenheimer reduced their price target on Teladoc Health from $14.00 to $12.00 and set an "outperform" rating on the stock in a report on Friday, January 24th. Royal Bank of Canada raised their target price on Teladoc Health from $11.00 to $12.00 and gave the stock an "outperform" rating in a research note on Friday, January 24th. Piper Sandler dropped their price target on Teladoc Health from $13.00 to $12.00 and set an "overweight" rating on the stock in a research note on Thursday, February 27th. Bank of America lifted their price objective on shares of Teladoc Health from $11.50 to $13.50 and gave the company a "neutral" rating in a research note on Wednesday, February 12th. Finally, The Goldman Sachs Group cut their target price on shares of Teladoc Health from $16.00 to $13.00 and set a "buy" rating on the stock in a research note on Monday, March 3rd. Eleven research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat.com, Teladoc Health has an average rating of "Hold" and an average target price of $11.26.

Teladoc Health Price Performance

Shares of Teladoc Health stock traded down $0.21 during trading on Monday, hitting $8.94. The stock had a trading volume of 2,723,245 shares, compared to its average volume of 8,293,557. The firm has a market cap of $1.55 billion, a price-to-earnings ratio of -1.55 and a beta of 1.27. Teladoc Health, Inc. has a 12 month low of $6.76 and a 12 month high of $15.95. The business's 50-day moving average is $10.62 and its 200 day moving average is $9.66. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66.

Teladoc Health (NYSE:TDOC - Get Free Report) last announced its quarterly earnings data on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.21) by ($0.07). The business had revenue of $640.49 million during the quarter, compared to analysts' expectations of $639.44 million. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. As a group, sell-side analysts anticipate that Teladoc Health, Inc. will post -1.16 earnings per share for the current year.

Teladoc Health Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.